Aardvark Therapeutics, Inc. Common Stock
AARDAardvark Therapeutics, Inc. (AARD) is a biotechnology company focused on developing innovative therapies for neurological and neurodegenerative diseases. The company leverages advanced scientific research to target these complex conditions, aiming to create effective treatment options.
$9.61 +0.24 (2.51%)
Company News
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Aardvark Therapeutics granted stock options to four new employees in October and November 2025, with options ranging from 14,766 to 49,849 shares, vesting over four years under their Inducement Equity Incentive Plan.
